News
Coave Therapeutics ('Coave'), a company pioneering the future of genetic medicines, today announces the evolution of its ...
Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi's M42 alongside strategic partnership Close of $76m Series B-1 tranche follows recent announcement of groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback